Biomaterial platforms for enhanced stem cell therapy in ischemic stroke
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Neurogenesis and neuroplasticity mechanisms · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. What is acute ischemic stroke?10.1001/jama.2022.1420 ↗
2. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 201910.1016/S1474-4422(21)00252-0 ↗
3. Advanced regenerative biomaterials for ischaemic stroke: a comprehensive therapeutic strategy10.1039/D5TB01227A ↗
4. Tissue engineering and biomaterial strategies to elicit endogenous neuronal replacement in the brain10.3389/fneur.2020.00344 ↗
5. Biomaterial-engineering and neurobiological approaches for regenerating the injured cerebral cortex10.1016/j.reth.2016.02.002 ↗
6. Stem cell therapy as a promising approach for ischemic stroke treatment
7. Safety and efficacy of bone marrow mesenchymal stem cells in the treatment of ischemic stroke: a meta-analysis10.4103/aian.aian_736_23 ↗
8. Current developments in cell- and biomaterial-based approaches for stroke repair10.1517/14712598.2016.1094457 ↗
9. Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: an approach for their use in neural regeneration therapies10.1371/journal.pone.0213032 ↗
10. Towards clinical translation of 'second-generation' regenerative stroke therapies: hydrogels as game changers?10.1016/j.tibtech.2021.10.009 ↗
11. Stem cell-based ischemic stroke therapy: novel modifications and clinical challenges
12. Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats10.1089/ten.tea.2010.0585 ↗
13. Application of cell transplantation in the treatment of neuropathic pain10.1016/j.neuroscience.2024.06.035 ↗
14. Neurorestorative approaches for ischemic StrokeChallenges, opportunities, and recent advances10.1016/j.neuroscience.2024.05.009 ↗
15. Clinical trials of stem cell therapy for cerebral ischemic stroke10.3390/ijms21197380 ↗
16. Non-human primate models of focal cortical ischemia for neuronal replacement therapy10.1177/0271678X231179544 ↗
17. Hydrogel-based therapies for ischemic and hemorrhagic stroke: a comprehensive review10.3390/gels10070476 ↗
18. Harnessing biomaterial application strategies for neurorestoration after ischemic stroke injury: an emerging treatment option
19. A review: carrier-based hydrogels containing bioactive molecules and stem cells for ischemic stroke therapy
20. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity10.1038/s41392-021-00830-x ↗
21. Mechanisms of ischemic brain damage10.1016/j.neuropharm.2008.01.005 ↗
22. Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment10.3892/ijmm.2021.5070 ↗
23. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions10.1038/s41392-022-01064-1 ↗
24. Functional differences between microglia and monocytes after ischemic stroke10.1186/s12974-015-0329-1 ↗
25. Dynamic brain lipid profiles modulate microglial lipid droplet accumulation and inflammation under ischemic conditions in mice
26. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation10.1007/s00281-018-0707-8 ↗
27. Stem cell transplantation for ischemic stroke
28. "Time Is Brain" - for cell therapies10.1002/advs.202519579 ↗
29. Stem cell-mediated recovery in stroke: partnering with the immune system10.1038/s41583-025-00985-4 ↗
30. Delayed transplantation of neural stem cells improves initial graft survival after stroke
31. Biomaterials-driven stem cell therapy for tissue repair and functional rehabilitation after ischemic stroke10.1002/btm2.70060 ↗
32. Update on cell therapy for stroke10.1136/svn-2017-000070 ↗
33. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke10.1212/WNL.0000000000000278 ↗
34. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats10.1016/j.lfs.2008.07.018 ↗
35. Locoregional delivery of stem cell-based therapies10.1126/scitranslmed.aba4564 ↗
36. Hypoxic preconditioned mesenchymal stromal cell therapy in a rat model of renal ischemia-reperfusion injury: development of optimal protocol to potentiate therapeutic efficacy10.15283/ijsc18073 ↗
37. Clinical efficacy and meta-analysis of stem cell therapies for patients with brain ischemia
38. Paracrine effects of mesenchymal stem cells in ischemic stroke: opportunities and challenges10.1007/s12035-022-02967-4 ↗
39. Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: is there a difference in biodistribution and efficacy?10.1016/j.scr.2012.02.002 ↗
40. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia10.1161/STROKEAHA.107.502047 ↗
41. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke10.1177/0271678X18776802 ↗
42. White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke10.1038/srep44433 ↗
43. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression10.5966/sctm.2015-0078 ↗
44. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury10.1038/nm.2736 ↗
45. Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing10.1186/s13287-023-03345-0 ↗
46. Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial10.1007/s12975-020-00787-z ↗
47. Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study10.1161/STROKEAHA.116.012995 ↗
48. Mesenchymal stem cell therapy for ischemic stroke: a look into treatment mechanism and therapeutic potential10.1007/s00415-020-10138-5 ↗
49. Mesenchymal stem cell homing: the devil is in the details10.1016/j.stem.2009.02.001 ↗
50. Stem cells for the treatment of neurological disorders10.1038/nature04960 ↗
51. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke10.1016/j.expneurol.2005.12.011 ↗
52. Stem cell-based cell therapy for neuroprotection in stroke: a review10.1002/jcb.28207 ↗
53. Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling10.1371/journal.pone.0009767 ↗
54. Brain repair mechanisms after cell therapy for stroke10.1093/brain/awae204 ↗
55. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex10.1073/pnas.0404474101 ↗
56. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis10.1038/nature01552 ↗
57. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats10.3727/000000001783986486 ↗
58. Neuronal replacement in stem cell therapy for stroke: filling the gap10.3389/fcell.2021.662636 ↗
59. Neuronal replacement: concepts, achievements, and call for caution10.1016/j.conb.2021.03.014 ↗
60. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery10.1093/brain/awt278 ↗
61. Human pluripotent stem-cell-derived cortical neurons integrate functionally into the lesioned adult murine visual cortex in an area-specific way10.1016/j.celrep.2018.04.094 ↗
62. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells10.1038/ncomms7626 ↗
63. Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks10.1186/s13287-017-0658-3 ↗
64. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development10.1016/j.stem.2013.04.005 ↗
65. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling10.1038/nbt.1529 ↗
66. Cross-talk between neural stem cells and immune cells: the key to better brain repair?10.1038/nn.3163 ↗
67. Synaptic inputs from stroke-injured brain to grafted human stem cell-derived neurons activated by sensory stimuli
68. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice10.1038/nm.4154 ↗
69. Induced pluripotent stem cell (iPSC)-Based neurodegenerative disease models for phenotype recapitulation and drug screening10.3390/molecules25082000 ↗
70. Induced pluripotent stem cells: past, present, and future10.1016/j.stem.2012.05.005 ↗
71. Directed differentiation of neurons from human iPSCs for modeling neurological disorders10.1007/978-1-0716-3810-1_12 ↗
72. ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors10.1038/ncb3598 ↗
73. Immunogenicity of induced pluripotent stem cells10.1038/nature10135 ↗
74. The tumorigenicity of human embryonic and induced pluripotent stem cells10.1038/nrc3034 ↗
75. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells10.1016/j.stem.2013.01.006 ↗
76. Materials to promote recovery after stroke10.1016/j.cobme.2020.04.002 ↗
77. Biomaterials to enhance stem cell transplantation10.1016/j.stem.2022.04.002 ↗
78. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
79. Hydrogel facilitated bioelectronic integration10.1039/D0BM01373K ↗
80. Recent advances in 3D hydrogel culture systems for mesenchymal stem cell-based therapy and cell behavior regulation10.1039/D1TB02537F ↗
81. Recapitulation of in vivo-like paracrine signals of human mesenchymal stem cells for functional neuronal differentiation of human neural stem cells in a 3D microfluidic system10.1016/j.biomaterials.2015.06.011 ↗
82. Advances in crosslinking strategies of biomedical hydrogels10.1039/C8BM01246F ↗
83. Stimuli‐responsive biomolecule‐based hydrogels and their applications10.1002/anie.201907670 ↗
84. The formation mechanism of hydrogels10.2174/1574888X12666170612102706 ↗
85. Hydrogel-based biomaterials for brain regeneration after stroke: gap to clinical translation
86. Recent advances in biodegradable and biocompatible synthetic polymers used in skin wound healing10.3390/ma16155459 ↗
87. Advancements in hydrogel application for ischemic stroke therapy10.3390/gels8120777 ↗
88. Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications10.1371/journal.pone.0231421 ↗
89. Hydrogels: properties and applications in biomedicine10.3390/molecules27092902 ↗
90. Chitosan, alginate, hyaluronic acid and other novel multifunctional hydrogel dressings for wound healing: a review10.1016/j.ijbiomac.2023.124321 ↗
91. Injectable silk sericin scaffolds with programmable shape-memory property and neuro-differentiation-promoting activity for individualized brain repair of severe ischemic stroke
92. Sliding fibers: slidable, injectable, and gel-like electrospun nanofibers as versatile cell carriers10.1021/acsnano.5b06605 ↗
93. ROS-Triggered biomimetic hydrogel soft scaffold for ischemic stroke repair10.1016/j.biomaterials.2025.123217 ↗
94. Peptide-responsive photonic hydrogels integrated with deep learning assistance for early MMP-9 detection10.1016/j.bios.2026.118444 ↗
95. In situ implantable, post-trauma microenvironment-responsive, ROS depletion hydrogels for the treatment of traumatic brain injury10.1016/j.biomaterials.2021.120675 ↗
96. Prospect of cell penetrating peptides in stem cell tracking10.1186/s13287-021-02522-3 ↗
97. Superparamagnetic iron oxide nanoparticles-complexed cationic amylose for in vivo magnetic resonance imaging tracking of transplanted stem cells in stroke10.3390/nano7050107 ↗
98. Peptide-based scaffolds support human cortical progenitor graft integration to reduce atrophy and promote functional repair in a model of stroke10.1016/j.celrep.2017.07.069 ↗
99. Cellular and molecular imaging for stem cell tracking in neurological diseases10.1136/svn-2020-000408 ↗
100. In vivo cell tracking using non-invasive imaging of iron oxide-based particles with particular relevance for stem cell-based treatments of neurological and cardiac disease10.1007/s11307-019-01440-4 ↗